Won Chan Lee

发表

PSY16 Cost and Quality of Life Benefits of Faster Bleed Resolution with an Rfviia Analogue: a Mathematical Simulation Study for the German Population

S. M. Pokras, A. A. Petrilla, J. Weatherall, 2011 .

Blood Pressure Lowering and Life Expectancy Based on a Markov Model of Cardiovascular Events

Robert J Glynn, Won Chan Lee, P. Lapuerta, 2003, Hypertension.

Cost of Self-Monitoring of Blood Glucose in the United States Among Patients on an Insulin Regimen for Diabetes

Won Chan Lee, M. Aagren, J. Yeaw, 2012, Journal of managed care pharmacy : JMCP.

Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide

Won Chan Lee, J. Bouchard, M. DeKoven, 2014, Advances in Therapy.

Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries

Won Chan Lee, M. DeKoven, V. Divino, 2014, Diabetes Therapy.

Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the UK, Germany, France, Spain and Italy (EU-5): results from a physician survey.

Won Chan Lee, S. Ray, M. DeKoven, 2012, Journal of comparative effectiveness research.

Human growth hormone treatment: synthesis of literature on product delivery systems and administration practices.

Won Chan Lee, M. Bhosle, M. Aagren, 2011, Journal for specialists in pediatric nursing : JSPN.

Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers.

Won Chan Lee, M. Aagren, T. Wisniewski, 2013, Journal of pediatric nursing.

Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis

Won Chan Lee, Y. Samyshkin, J. Langer, 2012, Journal of medical economics.

“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States

Won Chan Lee, M. Effron, G. Vetrovec, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs loose-dose combination of oral anti-diabetes drugs

Won Chan Lee, J. Mukherjee, T. Lokhandwala, 2016, Journal of medical economics.

Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes

Won Chan Lee, M. Wolden, D. Groleau, 2012, Diabetes Therapy.

The direct medical costs of Huntington’s disease by stage. A retrospective commercial and Medicaid claims data analysis

Won Chan Lee, D. Langbehn, K. Anderson, 2013, Journal of medical economics.

Drug Persistency Patterns for Patients Treated With Rivastigmine or Donepezil in Usual Care Settings

Won Chan Lee, J. Mauskopf, C. Paramore, 2005, Journal of managed care pharmacy : JMCP.

Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US

Won Chan Lee, C. Conner, M. Hammer, 2011, Current medical research and opinion.

Frequency of blood glucose testing among insulin-treated diabetes mellitus patients in the United Kingdom

Won Chan Lee, M. Wolden, B. Chubb, 2014, Journal of medical economics.

Safety Assessment of an Anti-Obesity Drug (Sibutramine)

Won Chan Lee, D. Oleske, J. Tyczynski, 2012, Drug Safety.

Impact of haemophilia with inhibitors on caregiver burden in the United States

Won Chan Lee, D. Cooper, W. C. Lee, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.